Advemto
4 known investors
Advemto maps complex cell function to genetic sequences at scale without requiring new laboratory instruments. The platform targets therapeutic development and TechBio companies seeking to accelerate preclinical validation of next-generation therapeutics.
Investors · 4
In the news
Frequently asked questions
- What does Advemto do?
- Advemto maps complex cell function to genetic sequences at scale without requiring new laboratory instruments. The platform targets therapeutic development and TechBio companies seeking to accelerate preclinical validation of next-generation therapeutics.
- Who are Advemto's investors?
- Advemto's investors include Booster Innovation Fund, Nuance Capital, NZ Growth Capital Partners, Enterprise Angels.